MarketPulse

targeted oncology

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Renovorx, Inc.

RenovoRx Lands Fast Company's Top 10 Innovative Medical Device Firms Amid RenovoCath Momentum

RenovoRx ($RNXT) earns Fast Company recognition as #10 innovative medical device firm, with $1.1M RenovoCath sales and Phase III pancreatic cancer trial advancing toward mid-2026 enrollment completion.
RNXTtargeted oncologyPhase III trial
GlobeNewswire Inc.GlobeNewswire Inc.··Mordor Intelligence

Precision Medicine Market Set to Double by 2031 on AI and Biomarker Advances

Precision medicine market expected to double to $237.28B by 2031, driven by AI advances and biomarker development at 13.58% annual growth.
ILMNABTRHHBYTMODHRAI integrationprecision medicine